Poland· PL-100016363
Cyclo-Progynova
A norgestrel und estrogen product containing estradioli valeras + norgestrelum, registered in Poland by Bayer AG. The same ATC class is registered in 3 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Norgestrel und estrogen is registered in 3 of 19 countries.
Countries holding a registration under ATC G03FB01 (norgestrel und estrogen), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 3 of them publish a price we can compare per daily dose
Norgestrel und estrogen · ATC G03FB01
3 / 19 countries
- Belgiumprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Estradioli valeras + Norgestrelum
- Manufacturer
- Bayer AG
- Country
- Poland (PL)
- ATC code
- G03FB01
- ATC class
- Norgestrel und Estrogen
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
1 priced- gtin0590999030421921 szt.PLN 10.12
- gtin05909990304226
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Norgestrel und estrogen in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandCyclacur
- United KingdomEstradiol valerate 2mg / Norgestrel 500microgram tabletsViatris UK Healthcare Ltd
- SpainPROGYLUTON COMPRIMIDOS RECUBIERTOSBayer Hispania S.L.
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- Belgium · Cyclocur
- Cyprus · Cyclacur
- Spain · Progyluton
- Greece · Cyclacur
- Romania · Cyclo-Progynova
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b043448c-6984-4aca-b4cb-55094c67fe81 GET /v1/drugs/b043448c-6984-4aca-b4cb-55094c67fe81?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "2 mg (białe), 2 mg + 0,5 mg (jasnobrązowe)",
"packaging": "05909990304219 ¦ Rp ¦ 2788\n21 tabl.\n05909990304226 ¦ Rp ¦ 57836\n63 tabl.",
"substance": "Estradioli valeras tabletki białe - 2,000 mg + Norgestrel tabletki jasnobrązowe - 0,500 mg + Estradioli valeras tabletki jasnobrązowe - 2,000 mg",
"common_name": "Estradioli valeras + Norgestrelum",
"pl_product_id": "100016363",
"pozwolenie_nr": "03042",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about norgestrel und estrogen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.